Recent studies showed that mTOR pathway activation plays critical roles in the pathogenesis of autoimmune diseases, including RA, immune thrombocytopenia, T1D, large-vessel vasculitis, and SLE. Here, MTOR is linked to autoimmune thrombocytopenic purpura.